Zandu Pharma to invest Rs 25 cr for Uttaranchal plant

4180 Investors following Zandu Realty. Share this News with them.

0

Like this story, share it with millions of investors on M3

Zandu Pharma to invest Rs 25 cr for Uttaranchal plant

Zandu Pharma is issuing bonus shares in the ratio 1:3. There are also other developments happening in the company, they are looking at expansion plans. Girish Parikh, Managing Director of Zandu Pharma says that the new plant in Uttaranchal will commence in April which will take up 50% of their production

Post your opinion here

 

0

Tweet

Share on Tumblr

Excerpts from Midcap Radar on CNBC-TV18 Watch the full show » ALSO READ See latest News about Zandu Realty See previous management interviews See what other Experts & Brokerages are saying about Zandu Realty Zandu Realty BSE | NSE 25/05/12 Are Mutual Funds betting on Zandu Realty?

Zandu Pharma is issuing bonus shares in the ratio 1:3. There are also other developments happening in the company, they are looking at expansion plans.

Girish Parikh, Managing Director of Zandu Pharma  says that the new plant in Uttaranchal will commence in April which will take up 50% of their production.

Excerpts from CNBC-TV18's exclusive interview with Girish Parikh:

Q: You are setting up a new plant at Uttaranchal, which is likely to be commissioned very soon, what is the capacity of that plant?

A: It will be around April, and it will take up about 50% of our productions.

Q: Once it gets commissioned, how much of an upside and revenue do you see coming in?

A: It is a new thing we are doing and bringing a radical change in one of the major products.

Q: How much of an investment will this plant see?

A: It will be about Rs 25 crore.

Q: You are involved in ayurvedic medicines, in gynecology and rheumatology. Are you looking at expanding any of these portfolios and any specific investments in the product launches?

A: The work is at the moment, in the pipeline in R&D level and by the end of next year we will be in the market with five to six new products.

Q: You are sitting at about two acres of land at Dadar, what is the value of the land and what will you be using this land for?

A: At the moment, we are having no plans to dispose it off. Let it be valued, our forefathers have bought it, they have given us inheritance, I know it is a very lucrative thing but I would like to use it for our own purposes. We have not bothered to know about the value of the land.

Q: Are you looking at setting up any facility in that area?

A: We are discussing it at board level.

Q: In terms of a growth rate of the pharma industries, to the herbal side of the business, it is about USD 61 billion and we have a growth rate of about 15-20%. Can that be superimposed in your company and would you expect it to grow about 15-20%?

A: Yes, we are growing. No doubt, in between some period was not good but now again we are regaining and I am confident that we will continue to grow as we have planned.